Stage I high-grade non-Hodgkin's lymphoma

Area of Science:

• Oncology
• Hematology
• Clinical Medicine

Background:

• High-grade lymphoma is a serious diagnosis.
• Understanding long-term outcomes and prognostic factors is crucial for patient management.

Purpose of the Study:

• To analyze long-term survival and identify prognostic factors in patients with stage I high-grade lymphoma.
• To evaluate the efficacy of radiation therapy in preventing relapse.

Main Methods:

• Retrospective analysis of 252 patients with stage I high-grade lymphoma.
• Assessment of patient demographics, clinical presentation, histology, treatment, and outcomes.
• Statistical analysis to determine prognostic significance of various factors and treatment outcomes.

Main Results:

• Younger age (<64 years) was associated with significantly better 5- and 15-year survival rates (83%/76% vs. 54%/46%).
• Negative prognostic factors included older age, non-centroblastic histology, B-symptoms, and elevated serum lactate dehydrogenase (LDH).
• Radiation therapy (40 Gy) demonstrated high efficacy in preventing in-field relapse (92%) with a low local relapse rate (1.7%).

Conclusions:

• Age is a critical prognostic factor in stage I high-grade lymphoma.
• Specific clinical and laboratory markers can help predict patient outcomes.
• Radiation therapy is an effective treatment for preventing local recurrence in stage I high-grade lymphoma.